Luca Beltrame
Luca Beltrame
Senior Scientist, Mario Negri Institute
Verified email at marionegri.it
Title
Cited by
Cited by
Year
Role of macrophage targeting in the antitumor activity of trabectedin
G Germano, R Frapolli, C Belgiovine, A Anselmo, S Pesce, M Liguori, ...
Cancer cell 23 (2), 249-262, 2013
5522013
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
S Marchini, D Cavalieri, R Fruscio, E Calura, D Garavaglia, IF Nerini, ...
The lancet oncology 12 (3), 273-285, 2011
1942011
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
S Marchini, R Fruscio, L Clivio, L Beltrame, L Porcu, IF Nerini, D Cavalieri, ...
European journal of cancer 49 (2), 520-530, 2013
1502013
Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy
FM Noe, N Polascheck, F Frigerio, M Bankstahl, T Ravizza, S Marchini, ...
Neurobiology of disease 59, 183-193, 2013
1252013
Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion
V Santarlasci, L Maggi, M Capone, V Querci, L Beltrame, D Cavalieri, ...
Immunity 36 (2), 201-214, 2012
1142012
Mode of action of trabectedin in myxoid liposarcomas
S Di Giandomenico, R Frapolli, E Bello, S Uboldi, SA Licandro, S Marchini, ...
Oncogene 33 (44), 5201-5210, 2014
1032014
Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation
A Aldinucci, L Rizzetto, L Pieri, D Nosi, P Romagnoli, T Biagioli, ...
The Journal of Immunology 185 (9), 5102-5110, 2010
992010
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy
V Iori, AM Iyer, T Ravizza, L Beltrame, L Paracchini, S Marchini, M Cerovic, ...
Neurobiology of disease 99, 12-23, 2017
862017
Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile
I Cifola, R Spinelli, L Beltrame, C Peano, E Fasoli, S Ferrero, S Bosari, ...
Molecular cancer 7 (1), 6, 2008
812008
Differential IL-17 production and mannan recognition contribute to fungal pathogenicity and commensalism
L Rizzetto, M Kuka, C De Filippo, A Cambi, MG Netea, L Beltrame, ...
The Journal of Immunology 184 (8), 4258-4268, 2010
592010
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients
G Della Vittoria Scarpati, E Calura, M Di Marino, C Romualdi, L Beltrame, ...
BioMed research international 2014, 2014
512014
IL‐4‐induced gene 1 maintains high T ob1 expression that contributes to TCR unresponsiveness in human T helper 17 cells
V Santarlasci, L Maggi, A Mazzoni, M Capone, V Querci, MC Rossi, ...
European journal of immunology 44 (3), 654-661, 2014
512014
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities
E Calura, R Fruscio, L Paracchini, E Bignotti, A Ravaggi, P Martini, ...
Clinical cancer research 19 (15), 4114-4123, 2013
512013
Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg
AS Baur, MB Lutz, S Schierer, L Beltrame, G Theiner, E Zinser, ...
Blood, The Journal of the American Society of Hematology 122 (13), 2185-2194, 2013
462013
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective …
M Petrillo, GF Zannoni, L Beltrame, E Martinelli, A DiFeo, L Paracchini, ...
Annals of Oncology 27 (4), 625-634, 2016
442016
The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus
R Vįzquez, ME Riveiro, L Astorgues-Xerri, E Odore, K Rezai, E Erba, ...
Oncotarget 8 (5), 7598, 2017
392017
A computational procedure to identify significant overlap of differentially expressed and genomic imbalanced regions in cancer datasets
S Bicciato, R Spinelli, M Zampieri, E Mangano, F Ferrari, L Beltrame, ...
Nucleic acids research 37 (15), 5057-5070, 2009
392009
Wiring miRNAs to pathways: a topological approach to integrate miRNA and mRNA expression profiles
E Calura, P Martini, G Sales, L Beltrame, G Chiorino, M D’Incalci, ...
Nucleic acids research 42 (11), e96-e96, 2014
382014
lncRNAs as novel indicators of patients' prognosis in stage I epithelial ovarian cancer: A retrospective and multicentric study
P Martini, L Paracchini, G Caratti, M Mello-Grand, R Fruscio, L Beltrame, ...
Clinical Cancer Research 23 (9), 2356-2366, 2017
372017
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: a validation across two independent cohorts
P Todeschini, E Salviato, L Paracchini, M Ferracin, M Petrillo, L Zanotti, ...
Cancer Letters 388, 320-327, 2017
352017
The system can't perform the operation now. Try again later.
Articles 1–20